Caplin Point Laboratories Limited has informed the Exchange regarding a press release dated September 24, 2021, titled "CAPLIN POINT S CRO AMARIS CLINICAL COMPLETES USFDA AUDIT WITH NIL OBSERVATIONS".
Press Release Sep 24 2021
Filed with NSE ·
6ix hasn’t read this filing yet.
Caplin Point Laboratories Limited on 6ix
Earlier from Caplin Point Laboratories
- Press Release Sep 08 2021
- Press Release Aug 17 2021
- Press Release Jul 14 2021
- Press Release Apr 23 2021
- Press Release Apr 22 2021
Later from Caplin Point Laboratories
- Press Release Aug 22 2022
- Press Release Feb 14 2023
- Press Release Mar 03 2023
- Press Release Mar 08 2023
- Press Release May 12 2023
Follow Caplin Point Laboratories into a list and get an email when it puts out news.
Follow Caplin Point Laboratories